Cartesian Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Cartesian Therapeutics, Inc. (RNAC) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $62.40 million as of 2022-12-31, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2023-11-13
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $62.40M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $51.10M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $234.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2022-12-31 | $62.40M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $51.10M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $234.50M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |